SCHEMBL890347

SCHEMBL890347

COc1ccc(/C=C/C(=O)OC(C)C(C=O)OC(=O)/C=C/c2ccc(OC)c(OC)c2)cc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
ALDH1A1 P00352 4/20 0.56
HPGD P15428 1/20 0.56
ALOX15 P16050 1/20 0.56
MAPK1 P28482 1/20 0.56
HSD17B10 Q99714 1/20 0.56
NFE2L2 Q16236 1/20 0.55
KMT2A Q03164 5/20 0.53
ABCG2 Q9UNQ0 2/20 0.53
MEN1 O00255 1/20 0.53
MAPT P10636 2/20 0.53
GLA P06280 1/20 0.53
HTT P42858 1/20 0.53
RECQL P46063 1/20 0.53
FDPS P14324 2/20 0.52
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
TTR P02766 1/20 0.49
TNFRSF1A P19438 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL730348 0.81 KDM4E (0.66) KDM4ESMN1; SMN2ALDH1A1HPGDALOX15
Methyl Cis-3,4-Dimethoxycinnamate SCHEMBL2411956 0.77 FDPS (0.80) KDM4ESMN1; SMN2ALDH1A1HPGDALOX15
Methyl Cis-3,4-Dimethoxycinnamate SCHEMBL2411955 0.77 FDPS (0.80) KDM4ESMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL8664544 0.75 KDM4E (0.65) KDM4ESMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL889739 0.75 KDM4E (0.66) KDM4ESMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL6336593 0.75 KDM4E (0.53) KDM4ESMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL6336601 0.75 KDM4E (0.53) KDM4ESMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL12538642 0.75 SMN1; SMN2 (0.69) KDM4ESMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL10929433 0.75 KDM4E (0.69) KDM4ESMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL3003953 0.75 NFE2L2 (0.71) KDM4ESMN1; SMN2ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110280848-A1 COMPOSITION COMPRISING CHICORIC ACID AND/OR DERIVATIVES THEREOF NESTEC S.A. (CH) 2011-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110280848-A1 COMPOSITION COMPRISING CHICORIC ACID AND/OR DERIVATIVES THEREOF LCT, LDHA, SI KDM4E 1347/4885SMN1; SMN2 3365/4885ALDH1A1 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.